Value Hunters: Look To AbCellera Biologics Inc (ABCL)
Currently, there are 298.36M common shares owned by the public and among those 223.95M shares have been available to trade. The company’s stock has a 5-day price change of 16.46% and 42.08% over the past three months. ABCL shares are trading 25.17% year to date (YTD), with the 12-month market performance up to 25.60% higher. […]
AbCellera Biologics Inc (ABCL): Street Finally Waking Up
Currently, there are 298.36M common shares owned by the public and among those 223.95M shares have been available to trade. The company’s stock has a 5-day price change of 3.31% and 32.77% over the past three months. ABCL shares are trading 6.48% year to date (YTD), with the 12-month market performance down to -6.31% lower. […]
AbCellera Biologics Inc (ABCL) Outlook Starting To Look Brighter?
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.23, with 20.07 million shares of worth about $64.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.67% during that period and on June 11, 2025 the price saw a […]
Some Investing Thoughts On AbCellera Biologics Inc (NASDAQ: ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.42, with 4.05 million shares of worth about $9.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.60% during that period and on June 04, 2025 the price saw a […]
Reviewing The Case For AbCellera Biologics Inc (ABCL) Going Higher
Currently, there are 298.36M common shares owned by the public and among those 223.95M shares have been available to trade. The company’s stock has a 5-day price change of 3.45% and -28.81% over the past three months. ABCL shares are trading -28.33% year to date (YTD), with the 12-month market performance down to -46.84% lower. […]
Analysts Update Their Price Forecasts For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.49, with 3.45 million shares of worth about $8.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.84% during that period and on May 01, 2025 the price saw a […]
Tomorrow Is Not Likely To Be Same For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.53, with 4.43 million shares of worth about $11.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.85% during that period and on April 23, 2025 the price saw a […]